An anterior ankle-foot orthosis improves walking economy in Charcot-Marie-Tooth type 1A patients

Prosthetics and Orthotics International

Volumn 38, Issue 5, 2014, Pages 387-392

  Menotti, Federica ^a   Laudani, Luca ^a   Damiani, Antonello ^b   Mignogna, Teresa ^c   Macaluso, Andrea ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b Unione Italiana Lotta alla Distrofia Muscolare   (Italy)

^c NuovoRegina Margherita Hospital   (Italy)

Author keywords

Gait; Hereditary neuromuscular disorder; Oxygen consumption; Rehabilitation of orthoses users; Walking energy cost

Indexed keywords

ADULT; ANKLE FOOT ORTHOSIS; ARTICLE; CLINICAL ARTICLE; ENERGY COST; FEMALE; GAIT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; METABOLISM; SHOE; TREATMENT OUTCOME; WALKING; WALKING SPEED; CHARCOT-MARIE-TOOTH DISEASE; COMPLICATION; CONTROLLED STUDY; ENERGY METABOLISM; FOOT ORTHOSIS; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; CHARCOT-MARIE-TOOTH DISEASE; ENERGY METABOLISM; FEMALE; FOOT ORTHOSES; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; SHOES; WALKING; YOUNG ADULT;

EID: 84920036577     PISSN: 03093646     EISSN: 17461553     Source Type: Journal    
DOI: 10.1177/0309364613506250     Document Type: Article

References (35)

1. Banchs I, Casasnovas C, Albertì A, et al. Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009; 1: 1-10.
2. Bamford NS, White KK, Robinett SA, et al. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A. Dev Med Child Neurol 2008; 51: 408-411.
3. Hattori N, Yamamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003; 126: 134-151.
4. Lindeman E, Spaans F, Reulen JPH, et al. Surface EMG of proximal leg muscles in neuromuscular patients and in healthy controls. Relations to force and fatigue. J Electromyogr Kinesiol 1999; 9: 299-307.
5. Kilmer DD. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002; 81: 121-126.
6. Schillings ML, Kalkman JS, Janssen HM, et al. Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 2007; 118: 292-300.
7. Menotti F, Bazzucchi I, Felici F, et al. Neuromuscular function after muscle fatigue in Charcot-Marie-Tooth type 1A patients. Muscle Nerve 2012; 46: 434-439.
8. Geurts AC, Mulder TW, Nienhuis B, et al. Postural organization in patients with hereditary motor and sensory neuropathy. Arch Phys Med Rehabil 1992; 73: 569-572.
9. Carter GT, Jensen MP, Galer BS, et al. Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 1998; 79: 1560-1564.
10. Padua L, Shy ME, Aprile I, et al. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst 2008; 13: 64-70.
11. Wright NC, Kilmer DD, McCrory MA, et al. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996; 77: 64-69.
12. McCrory M, Kim H, Wright N, et al. Energy expenditure, physical activity, and body composition of ambulatory adults with hereditary neuromuscular disease. Am J Clin Nutr 1998; 67: 1162-1169.
13. Mazzaro N, Grey MJ, Sinkjær T, et al. Lack of on-going adaptations in the soleus muscle activity during walking in patients affected by large-fiber neuropathy. J Neurophysiol 2005; 93: 3075-3085.
14. Don R, Serrao M, Vinci P, et al. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech 2007; 22: 905-916.
15. Vinci P. Persistence of range of motion in dorsiflexion when the triceps surae muscle weaken, worsens stance in Charcot-Marie-Tooth disease. Eura Medicophys 2006; 42: 219-222.
16. Kuruvilla A, Costa JL, Wright RB, et al. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease. Neurol India 2000; 48: 49-55.
17. Menotti F, Felici F, Damiani A, et al. Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals. Neuromuscul Disord 2011; 21: 52-57.
18. Vinci P and Gargiulo P. Poor compliance with ankle-footorthoses in Charcot-Marie-Tooth disease. Eur J Phys Rehabil Med 2008; 27-31.
19. Guillebastre B, Calmels P and Rougier PR. Assessment of appropriate ankle-foot orthoses models for patients with Charcot-Marie-Tooth disease. Am J Phys Med Rehabil 2011; 90: 619-627.
20. Phillips MF, Robertson Z, Killen B, et al. A pilot study of a crossover trial with randomized use of ankle-foot orthoses for people with Charcot-Marie-Tooth disease. Clin Rehabil 2012; 26: 534-544.
21. Ramdharry GM, Day BL, Reilly MM, et al. Foot drop splints improve proximal as well as distal leg control during gait in Charcot-Marie-Tooth disease. Muscle Nerve 2012; 46: 512-519.
22. Vinci P, Paoloni M, Ioppolo F, et al. Gait analysis in a patient with severe Charcot-Marie-Tooth disease: a case study with a new orthotic device for footdrop. Eur J Phys Rehabil Med 2010; 46: 355-361.
23. Guzian MC, Bensoussan L, Viton JM, et al. Orthopaedic shoes improve gait in a Charcot-Marie-Tooth patient: a combined clinical and quantified case study. Prosthet Orthot Int 2006; 1: 87-96.
24. Bean J, Walsh A and Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease a single-subject design. Am J Phys Med Rehab 2001; 80: 578-582.
25. Ramdharry GM, Pollard AJ, Marsden JF, et al. Comparing gait performance of people with Charcot-Marie-Tooth disease who do and do not wear ankle foot orthoses. Physiother Res Int 2012; 17: 191-199.
26. Phillips M, Radford K and Wills A. Ankle foot orthoses for people with Charcot Marie Tooth disease - views of users and orthotists on important aspects of use. Disabil Rehabil Assist Technol 2011; 6: 491-499.
27. Bernardi M, Macaluso A, Sproviero E, et al. Cost of walking and locomotor impairment. J Electromyogr Kinesiol 1999; 9: 149-157.
28. Jacelon CS. The Barthel index and other indices of functional ability. Rehabil Nurs 1986; 11: 9-11.
29. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986; 34: 119-126.
30. Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty's Stationery Office, 1976.
31. Duffield R, Dawson B, Pinnington H, et al. Accuracy and reliability of a Cosmed K4b2 portable gas analysis system. J Sci Med Sport 2004; 7: 11-22.
32. Thomas EE, De Vito G and Macaluso A. Physiological costs and temporo-spatial parameters of walking on a treadmill vary with body weight unloading and speed in both healthy young and older women. Eur J Appl Physiol 2007; 100: 293-299.
33. Thomas EE, De Vito G and Macaluso A. Speed training with body weight unloading improves walking energy cost and maximal speed in 75-85 year old healthy women. J Appl Physiol 2007; 103: 1598-1603.
34. Danielsson A and Sunnerhagen KS. Energy expenditure in stroke subjects walking with a carbon composite ankle foot orthosis. J Rehabil Med 2004; 36: 165-168.
35. Hachisuka K, Makino K, Wada F, et al. Oxygen consumption, oxygen cost and physiological cost index in polio survivors: a comparison of walking without orthosis, with an ordinary or a carbon-fibre reinforced plastic knee-ankle-foot orthosis. J Rehabil Med 2007; 39: 646-650.